2 years ago
MultiplAI Health Raises $2.7 Million for AI-Powered Blood Screening Tests
MultiplAI Health, a London-based biotech diagnostics company, has raised $2.7 million in seed funding led by Zentynel, SF500 and Time Partners
The company is developing blood screening tests using RNA Sequencing and Artificial Intelligence to detect complex diseases, including cardiovascular disorders and cancer
The investment will help MultiplAI expand its operations in the US and continue developing its AI-powered blood screening tests.